Clinical features of COVID-19 in Pediatric Patients, long term effects (COPP2-study).

Completed

• Conditions: corona; SARS-CoV-2; 10027665; 10047438; 10024970

• Registration Number: NL-OMON55281
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

Children age 0-17 years, in- or outpatient in Dutch hospitals with a medical
history of COVID-19.
inclusion in COPP study

Exclusion Criteria

- No evidence of COVID-19
- No consent from guardians and/or patient.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>long-term morbidity, defined as:<br /><br>o Frequency of symptoms, hospital readmission, emergency department or GP<br /><br>visits for symptoms, antibiotic courses for pulmonary infections or start of<br /><br>inhaled corticosteroids and/or b2-mimetics after admission for COVID-19 since<br /><br>diagnosis of COVID-19;<br /><br>o The immunological profile of children at 4-12 months of follow-up after<br /><br>presenting to Dutch hospitals with COVID-19 or MIS-C</p><br>